Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
Over the last decades, the astonishing properties of carbon nanomaterials have attracted scientific interest and efforts to improve their potential has been made. The unique electrical, optical and mechanical properties have encouraged the continuous research breakthroughs, hence accelerating the commercialisation process.
“Danish life science is heading for a new golden age”! This is one of the statements put forward in today´s article in Danish daily, Berlingske, highlighting MVA-member, Bioinnovation Institute, and their role as incubator for promising life science companies.
Made in Oslo by a team of researchers from Oslo University Hospital, the first ever Norwegian CAR T cell is now a fact. A potential treatment based on this result depends on a clinical study.
Another new award, this category highlights the supplier with the largest percentage increase in ELISA kit citations over the past year. This award was designed to recognise those suppliers that have a smaller citation share who might be about to take off in this market in a big way!
A second group of patients have been added to an ongoing phase II clinical study of a drug combination to treat lung cancer.
The spring call for proposals for eight beamlines at MAX IV closed 19 March with a total of 228 proposals from 28 countries. The number of applications is on par with proposals received when the former MAX-lab peaked, which shows that the demand from users is high as well as is their confidence in getting excellent tools and support.